Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCR/P(i) in patients with severe hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 80, Issue 3 A, 1997, Pages 34A-40A

  Sieverding, Ludger ^a,b   Jung, Wulf Ingo ^a,b   Breuer, Johannes ^a,b   Widmaier, Stefan ^a,b   Staubert, Andreas ^a,b   Van Erckelens, Franz ^a,b   Schmidt, Oliver ^a,b   Bunse, Michael ^a,b   Hoess, Thomas ^a,b   Lutz, Otto ^a,b   Dietze, Guenther J ^a,b   Apitz, Jürgen ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Max Grundig Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; ENERGY METABOLISM; EXCITATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; NUCLEAR OVERHAUSER EFFECT; OXYGEN SUPPLY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON TRANSPORT; SCORING SYSTEM; SEQUENCE ANALYSIS;

EID: 0030801554     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00456-6     Document Type: Conference Paper

References (35)

1. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 8:1986;545-557.
2. Maron BJ, Wolfson JK, Roberts WC. Relation between extent of cardiac muscle cell disorganization and left ventricular wall thickness in hypertrophic cardiomyopathy. Am J Cardiol. 70:1992;785-790.
3. Seidman CE, McKenna W, Watkins HC, Seidman FG. Molecular genetic approaches to diagnosis and management of hypertrophic cardiomyopathy. Braunwald E. Heart Disease Update. 1992;435-442 WB Saunders, Philadelphia.
4. Camici P, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G, Parodi O, Salvadori PA, Nista N, Papi L, L'Albite A. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol. 17:1991;879-886.
5. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med. 330:1994;913-919.
6. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med. 323:1990;1593-1600.
7. Bottomley PA. MR spectroscopy of the human heart: the status and the challenges. Radiology. 191:1994;593-612.
8. 31 MR spectroscopy. J Magn Reson Imaging. 2:1992;711-719.
9. 31P MR spectroscopy in hypertrophic cardiomyopathy: comparison with Tl-201 myocardial perfusion imaging. Am Heart J. 125:1993;1323-1328.
10. Masuda Y, Tateno Y, Ikehira H, Hashimoto T, Shishido F, Sekiya M, Imazeki Y, Imai H, Watanabe S, Inagaki Y. High-energy phosphate metabolism of the myocardium in normal subjects and patients with various cardiomyopathies - a study using ECG gated MR spectroscopy with a localization technique. Jpn Circ J. 56:1992;620-626.
11. rd Annual Meeting of the Society of Magnetic Resonance, Nice. 92:1995.
12. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation. 86:1992;1810-1818.
13. 31P magnetic resonance spectroscopy. Lancet. 338:1991;973-976.
14. 31P NMR spectroscopy. The noninvasive tool for the study of the biochemistry of the cardiovascular system. Trends Cardiovasc Med. 3:1993;29-37.
15. Jung WI, Widmaier S, Seeger U, Bunse M, Staubert A, Sieverding L, Straubinger K, van Erckelens F, Schick F, Dietze G, Lutz O. Phosphorus J coupling constants of ATP in human myocardium and calf muscle. J Magn Reson B. 110:1996;39-46.
16. 2+ in intact frog skeletal muscle. J Biol Chem. 255:1980;3987-3993.
17. 31P NMR spectroscopy. Magn Reson Med. 24:1992;163-169.
18. 31P magnetic resonance. J Biol Chem. 248:1973;7276-7278.
19. Shaka AJ, Keeler J, Freeman R. Evluation of a new broadband decoupling sequence: WALT2-16. J Mgn Reson. 53:1983;313-340.
20. Cholevas V, Challa A, Lapatsanis D, Andronikou S. Phosphate metabolism in the red cell of sick prematures. Bone Miner. 22:1993;177-185.
21. 31P-NMR spectroscopy of human blood and serum: first results from volunteers and patients with congestive heart failure, diabetes mellitus and hyperlipidaemia. MAGMA. 1:1993;55-60.
22. Bottomley PA, Ouwerkerk R. Optimum flip-angles for exciting NMR with uncertain T1 values. Magn Reson Med. 32:1994;137-141.
23. Bottomley PA, Hardy CJ. Proton Overhauser enhancements in human cardiac phosphorus NMR spectroscopy at 1.5 T. Magn Reson Med. 24:1992;384-390.
24. 31P nuclear magnetic resonance spectroscopy. Neurology. 35:1985;781-788.
25. Clarke C, Kashiwaya Y, King MT, Gates D, Keon CA, Cross HR, Radda GK, Veech RL. The β/α peak height ratio of ATP. J Biol Chem. 271:1996;21142-21150.
26. O'Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, Bacharach SL, Larson SM, Epstein SE. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation. 76:1987;1214-1223.
27. Louie EK, Maron BJ. Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance. J Am Coll Cardiol. 8:1986;57-65.
28. Betocchi S, Hess OM, Losi MA, Nonogi H, Krayenbuehl HP. Regional left ventricular mechanics in hypertrophic cardiomyopathy. Circulation. 88:1993;2206-2214.
29. Nienhaber CA, Gambhir SS, Mody FV, Ratib O, Huang SC, Phelps ME, Schelbert HR. Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy. Circulation. 87:1993;1580-1590.
30. Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical β -myosin heavy chain gene mutations. Circulation. 89:1994;22-32.
31. Schaefer S, Schwartz GG, Gober JR, Wong AK, Camacho SA, Massie B, Weiner MW. Relationship between myocardial metabolites and contractile abnormalities during graded regional ischemia. Phosphorus-31 nuclear magnetic resonance studies of porcine myocardium in vivo. J Clin Invest. 85:1990;706-713.
32. Schaefer S, Schwartz GG, Wisneski JA, Trocha SD, Christoph I, Steinman SK, Garcia J, Massie BM, Weiner MW. Response of high-energy phosphates and lactate release during prolonged regional ischemia in vivo. Circulation. 85:1992;342-349.
33. Bristow JD, Arai AE, Anselone CG, Pantely GA. Response to myocardial ischemia as a regulated process. Circulation. 84:1991;2580-2587.
34. Arai AE, Pantely GA, Anselone CG, Bristow J, Bristow JD. Active downregulation of myocardial energy requirements during prolonged moderate ischemia in swine. Circ Res. 69:1991;1458-1469.
35. Arai AE, Grauer SE, Anselone CG, Pantely GA, Bristow JD. Metabolic adaptation to a gradual reduction in myocardial blood flow. Circulation. 92:1995;244-252.